13F-HR filed by TANG CAPITAL MANAGEMENT LLC
TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-15, with 7 holding rows worth $241,111,000.
- Accession
- 0001214659-16-014680
- Filer
- CIK 1232621
- Filed
- 2016-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2016
A holdings report, 8 entries on the cover page, a total value of $241,111,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $241,111,000 with VALUE read as thousands by filing date, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerTANG KEVIN C028-14818
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HERON THERAPEUTICS INC | 427746102 | COM | 6,197,198 | $106,778,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 3,191,165 | $75,918,000 | thousands by filing date | |
| IGNYTA INC | 451731103 | COM | 3,972,800 | $24,989,000 | thousands by filing date | |
| OPKO HEALTH INC | 68375NAB9 | DEBT 3.000% 2/0 | 14,000,000 | $22,031,000 | thousands by filing date | principal |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 90,215 | $8,347,000 | thousands by filing date | |
| CYCLACEL PHARMACEUTICALS INC | 23254L405 | COM PAR | 359,900 | $2,159,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120103 | COM | 279,425 | $889,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-16-014680 | this filing | 2016-11-15 | acceptance time not in the bulk data set |